Skip to Main Nav Skip to Content
Go to the main menu
*All treatments were administered as 2 inhalations twice daily. †The incidence of common adverse events in the table above is based upon three 12-week, double-blind, placebo-controlled US clinical trials in which 401 adult and adolescent patients aged 12 years and older were treated twice daily with 2 inhalations of SYMBICORT 80/4.5 mcg or SYMBICORT 160/4.5 mcg, budesonide HFA metered-dose inhaler (MDI) 80 or 160 mcg, formoterol dry powder inhaler (DPI) 4.5 mcg, or placebos (MDI and DPI).
Download a free Flash player now.
What's the right dose for my patient?
Learn more about the recommended dosing of SYMBICORT.
Questions abouttolerability?
Learn more about the safety and tolerability of SYMBICORT.
Patients need helpusing their inhaler?
This video can give theinstructions they need.
Looking for helpful tools?
Nationwide, over 80% of patients with prescription drug coverage pay a Tier 1 or Tier 2 copay.1*
Use the free formulary status tool to quickly determine the formulary status of SYMBICORT in your area.
*Individual costs may vary by plan.
The new SYMBICORT Mobile site gives you anytime, anywhere access to helpful tools and resources.
Whether it's help affording medication or living with asthma, you'll find valuable resources for patient support.